Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of 3.68% is in line with its 5-year average of 3.98%, near the low end of its 5-year range (3.31%–10.70%).
0.74% above its 12-month average of 3.65%.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): 3.74%.
NET PROFIT MARGIN
3.68%
NET PROFIT MARGIN AVG TTM
3.65%
NET PROFIT MARGIN AVG 3Y
4.08%
NET PROFIT MARGIN AVG 5Y
3.98%
NET PROFIT MARGIN AVG 10Y
0.02%
NET PROFIT MARGIN AVG 15Y
-1.73%
NET PROFIT MARGIN AVG 20Y
-1.67%
CURRENT VS TTM AVG
+0.74%
CURRENT VS 3Y AVG
-9.73%
CURRENT VS 5Y AVG
-7.57%
CURRENT VS 10Y AVG
+18507.94%
CURRENT VS 15Y AVG
+312.24%
CURRENT VS 20Y AVG
+320.62%
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 703 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Option Care Health, Inc.
Market Cap
$4.65B
Net Profit Margin
3.68%
TTM Avg
3.65%
3Y Avg
4.08%
5Y Avg
3.98%
Market Cap
$4.62B
Net Profit Margin
8.43%
TTM Avg
-12.40%
3Y Avg
-46.69%
5Y Avg
-46.69%
Market Cap
$4.70B
Net Profit Margin
3.19%
TTM Avg
-1.95%
3Y Avg
-11.66%
5Y Avg
-17.12%
Market Cap
$4.74B
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$4.45B
Net Profit Margin
-20.73%
TTM Avg
-55.30%
3Y Avg
-87.73%
5Y Avg
-105.64%
Market Cap
$4.44B
Net Profit Margin
26.65%
TTM Avg
8.56%
3Y Avg
0.11%
5Y Avg
0.58%
Market Cap
$4.86B
Net Profit Margin
-1570.85%
TTM Avg
-4668.05%
3Y Avg
-2830.27%
5Y Avg
-2034.87%
Market Cap
$4.86B
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$4.91B
Net Profit Margin
-139.18%
TTM Avg
-15.29%
3Y Avg
-73.58%
5Y Avg
-122.19%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Option Care Health, Inc. (OPCH) | $4.65B | 3.68% | 3.65% | 4.08% | 3.98% |
| BillionToOne, Inc. (BLLN)vs › | $4.62B | 8.43% | -12.40% | -46.69% | -46.69% |
| LifeStance Health Group, Inc. (LFST)vs › | $4.70B | 3.19% | -1.95% | -11.66% | -17.12% |
| Definium Therapeutics, Inc. (DFTX)vs › | $4.74B | 0.00% | 0.00% | 0.00% | 0.00% |
| Adaptive Biotechnologies Corporation (ADPT)vs › | $4.45B | -20.73% | -55.30% | -87.73% | -105.64% |
| Indivior Pharmaceuticals Inc (INDV)vs › | $4.44B | 26.65% | 8.56% | 0.11% | 0.58% |
| Dianthus Therapeutics, Inc. (DNTH)vs › | $4.86B | -1570.85% | -4668.05% | -2830.27% | -2034.87% |
| Oruka Therapeutics, Inc. (ORKA)vs › | $4.86B | 0.00% | 0.00% | 0.00% | 0.00% |
| Mirum Pharmaceuticals, Inc. (MIRM)vs › | $4.91B | -139.18% | -15.29% | -73.58% | -122.19% |
| Edgewise Therapeutics, Inc. (EWTX)vs › | $4.38B | 0.00% | 0.00% | 0.00% | 0.00% |
Operating Margin
5.9%
Net Profit Margin
3.7%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | 3.74% |
| 2026-03-31 | 3.36% |
| 2025-12-31 | 3.99% |
| 2025-09-30 | 3.61% |
| 2025-06-30 | 3.57% |
| 2025-03-31 | 3.51% |
| 2024-12-31 | 4.47% |
| 2024-09-30 | 4.21% |
| 2024-06-30 | 4.32% |
| 2024-03-31 | 3.91% |
| 2023-12-31 | 5.09% |
| 2023-09-30 | 5.15% |
| 2023-06-30 | 10.70% |
| 2023-03-31 | 3.86% |
| 2022-12-31 | 4.63% |
| 2022-09-30 | 3.80% |
| 2022-06-30 | 3.46% |
| 2022-03-31 | 3.31% |
| 2021-12-31 | 8.14% |
| 2021-09-30 | 3.98% |
| 2021-06-30 | 3.70% |
| 2021-03-31 | -0.38% |
| 2020-12-31 | 2.22% |
| 2020-09-30 | 0.21% |
| 2020-06-30 | -1.04% |
| 2020-03-31 | -2.82% |
| 2019-12-31 | -2.19% |
| 2019-09-30 | -6.95% |
| 2019-06-30 | -8.18% |
| 2019-03-31 | -0.78% |
| 2018-12-31 | -8.37% |
| 2018-09-30 | -4.52% |
| 2018-06-30 | -8.61% |
| 2018-03-31 | -7.72% |
| 2017-12-31 | -1.67% |
| 2017-09-30 | -6.54% |
| 2017-06-30 | -13.54% |
| 2017-03-31 | -9.05% |
| 2016-12-31 | -5.19% |
| 2016-09-30 | -5.02% |
| 2016-06-30 | -3.54% |
| 2016-03-31 | -4.00% |
| 2015-12-31 | -7.57% |
| 2015-09-30 | -6.79% |
| 2015-06-30 | -99.15% |
| 2015-03-31 | -8.05% |
| 2014-12-31 | -25.08% |
| 2014-09-30 | -16.72% |
| 2014-06-30 | -8.02% |
| 2014-03-31 | -10.58% |
| 2013-12-31 | -7.62% |
| 2013-09-30 | -17.88% |
| 2013-06-30 | -5.15% |
| 2013-03-31 | -4.49% |
| 2012-12-31 | 3.97% |
| 2012-09-30 | -6.77% |
| 2012-06-30 | 46.03% |
| 2012-03-31 | -1.74% |
| 2011-12-31 | 1.39% |
| 2011-09-30 | 0.41% |
| 2011-06-30 | -1.77% |
| 2011-03-31 | 2.25% |
| 2010-12-31 | -14.89% |
| 2010-09-30 | 0.45% |
| 2010-06-30 | 0.76% |
| 2010-03-31 | -2.14% |
| 2009-12-31 | 11.91% |
| 2009-09-30 | 1.72% |
| 2009-06-30 | 1.33% |
| 2009-03-31 | 1.01% |
| 2008-12-31 | -20.89% |
| 2008-09-30 | 0.39% |
| 2008-06-30 | 0.46% |
| 2008-03-31 | -0.15% |
| 2007-12-31 | 0.82% |
| 2007-09-30 | 0.56% |
| 2007-06-30 | 0.16% |
| 2007-03-31 | -0.45% |
| 2006-12-31 | -9.59% |
| 2006-09-30 | -1.21% |
| 2006-06-30 | -2.04% |
| 2006-03-31 | -0.39% |
| 2005-12-31 | -7.43% |
| 2005-09-30 | 0.22% |
| 2005-06-30 | -1.24% |
| 2005-03-31 | 0.88% |
| 2004-12-31 | 0.71% |
| 2004-09-30 | 1.07% |
| 2004-06-30 | 1.26% |
| 2004-03-31 | 1.47% |
| 2003-12-31 | 0.71% |
| 2003-09-30 | 0.96% |
| 2003-06-30 | 2.18% |
| 2003-03-31 | 2.10% |
| 2002-12-31 | 2.91% |
| 2002-09-30 | 3.24% |